Update Enrollment in the New Clozapine REMS Program

Please see the FDA notice concerning Clozapine REMS program updates/deadline extensions.

A SINGLE new registry will streamline clozapine management.

We know clozapine is very effective for schizophrenia...but it's often a last resort due to neutropenia risk and its complex monitoring.

The new Clozapine REMS Program is now the ONLY registry available.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals